Statement of Care of Anemia in Delivering Patients at Nord Franche-Comte Hospital (ANEMIA)

March 15, 2022 updated by: Hopital Nord Franche-Comte
Anemia is a common pregnancy condition that has multiple origins. Its frequency and severity seem to be increasing, despite the existing management recommendations and the awareness of health professionals. The objective of this study is to make a statement of this pathology within our establishment, to evaluate the proportion of patients presenting this pathology and to highlight possible risk factors.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

1177

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Trévenans, France, 90400
        • Hôpital Nord Franche-Comté

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

All patients presenting eligibility criteria and giving birth at NFC Hospital

Description

Inclusion Criteria:

  • > 18 years
  • Delivery at Nord Franche-Comte Hospital
  • Delivery ≥ 32 weeks of amenorrhea
  • Informed patient and non-opposition of participation

Exclusion Criteria:

  • Protected adults (Patients under guardianship, curatorship, safeguard of justice or under family authorization)
  • Medical interruption of pregnancy
  • Patients with fetal death in utero or neonatal death
  • Minor patients
  • Premature delivery before 32 weeks

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Estimation of the proportion of patients presenting anemia during delivery
Time Frame: 6 month
Percentage of patients with hemoglobin less than 10.5 g/dl at entry into the delivery room
6 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk factors underlying anemia during delivery with a large questionnaire
Time Frame: 6 month
Link between presence or absence of anemia and type of follow-up (gynecological or midwife, anemia during pregnancy and iron supplementation strategy and compliance), living conditions (geographical origin, socioeconomic situation, diet) and comorbidities
6 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 12, 2021

Primary Completion (Actual)

October 12, 2021

Study Completion (Actual)

March 15, 2022

Study Registration Dates

First Submitted

March 16, 2021

First Submitted That Met QC Criteria

March 22, 2021

First Posted (Actual)

March 24, 2021

Study Record Updates

Last Update Posted (Actual)

March 16, 2022

Last Update Submitted That Met QC Criteria

March 15, 2022

Last Verified

March 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2019-02

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy Anemia

Clinical Trials on questionnaire

Subscribe